Click Holdings Limited (NASDAQ:CLIK) Sees Significant Drop in Short Interest

Click Holdings Limited (NASDAQ:CLIK) saw a significant decrease in short interest in January. As of January 30th, there was short interest totaling 2,237 shares, a decrease of 35.1% from the January 15th total of 3,446 shares. Based on an average daily volume of 6,248 shares, the short-interest ratio is presently 0.4 days. Approximately 0.2% of the company’s shares are sold short. Approximately 0.2% of the company’s shares are sold short. Based on an average daily volume of 6,248 shares, the short-interest ratio is presently 0.4 days.

Click Price Performance

Shares of CLIK stock opened at $3.59 on Friday. Click has a 52 week low of $3.24 and a 52 week high of $102.90. The firm has a 50 day moving average of $5.09 and a two-hundred day moving average of $7.34.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.